Leptomeningeal Disease Diagnosis in Diffuse Midline Gliomas Achieved via ctDNA Detection
Researchers diagnosed leptomeningeal disease in diffuse midline gliomas by detecting H3K27M-mutant ctDNA from cerebrospinal fluid.
Category: Unknown Origin & Other Cancer Types
Unknown Origin & Other Cancer Types
Latest
Unknown Origin & Other Cancer Types
Latest
AI-Powered Blood Test Enhances Early Detection of Ovarian Cancer
An AI-powered blood test combining DNA fragment analysis with protein biomarkers significantly improves early ovarian cancer detection.
Unknown Origin & Other Cancer Types
Latest
Blood Test May Guide Use of Multiple Myeloma Immunotherapy
A blood test measuring lymphocyte levels may predict the effectiveness of CAR-T immunotherapy in relapsed multiple myeloma patients.
Ovarian Cancer Detection Method Improvement Over CA125
Mercy BioAnalytics will present data showing that their Mercy Halo test significantly improves early detection of ovarian cancer.
Read More
New Biomarkers Identified for Improve Renal Cancer Diagnosis
Researchers discovered new biomarkers for renal cell carcinomas, enhancing the diagnosis of various subtypes.
Read More
Leptomeningeal Cancer Cell Diagnostic Assay Gets Clinical Trial Implementation
The tumor cell enumeration assay is a diagnostic test that is promising for establishing the diagnosis of leptomeningeal metastases.
Read More
Myriad Genetics Receives Patent for High-Definition MRD Assay
The U.S. Patent and Trademark Office issued a patent to Myriad Genetics aimed at strengthening its ability to deliver a MRD assay to market.Â
Read More
New Test Could Identify Aggressive Ovarian Cancers Early
A new algorithm may help identify high-risk precancerous lesions on the fallopian tubes thought to lead to a common form of ovarian cancer
Read More
Bladder Cancer LDT Receives Medicare Coverage
The Oncuria Bladder Cancer Tests, a DiaCarta validated lab developed test (LDT), received Medicare coverage effective Jan. 1, 2024.
Read More
New Terahertz Biosensor Detects Skin Cancer with High Accuracy
Researchers have developed a new biosensor using terahertz waves that can detect skin cancer with improved sensitivity.
Read More
Lucid Diagnostics Contracts to Cover Esophageal Precancer Testing for 9/11 Responders and Survivors
Lucid Diagnostics has contracted with the World Trade Center Health Program to provide the EsoGuard Esophageal DNA test as a covered benefit.
Read More
Sophia Genetics and AstraZeneca Spain to Increase Ovarian Cancer Testing in Spain
The program started in 2022 when AstraZeneca and Sophia Genetics collaborated to deploy HRD testing to five labs throughout the country.
Read More
Researchers Leverage AI for Early Diagnostic Test for Ovarian Cancer
Scientists combined machine learning with info on blood metabolites to develop a new test able to detect ovarian cancer with 93% accuracy.
Read More
Researchers Use Liquid Biopsies to Detect Relapse of Childhood Cancer Early
The study will collect small blood samples several times from 150 patients with high-risk neuroblastoma to be examined in laboratories.
Read More
Protein Biomarker Identified for Aggressive Neuroendocrine Carcinomas Diagnosis
New research is guiding the development of blood tests to detect and monitor responses to therapies in neuroendocrine carcinomas patients.
Read More
Test to Guide Radiation Therapy for Skin Cancer Patients Could Save Millions in Medicare Costs
The DecisionDx-SCC test guides adjuvant radiation therapy (ART) decisions for patients with squamous cell carcinoma (SCC).
Read More
Brush Biopsy Enables Early Oral Cancer Detection
Researchers invented a new test that uses a small brush to allow dentists to screen for the most common form of oral cancer.
Read More
Obesity Linked to Detection of Blood Cancer Precursor
Individuals with obesity are more likely to have MGUS, a benign blood condition that often precedes multiple myeloma.
Read More